Summary
The ability of two supposed DNA-repair inhibitors to modulate cisplatin-induced cytotoxicity in a human ovarian cancer cell line (CAOV-3) and a human cervical cancer cell line (Me-180) was investigated using a short-term chemosensitivity assay based on bioluminescence of cellular adenosine triphosphate (ATP). Cisplatin concentrations bracketing the reported peak plasma concentration (2.5 μg/ml) were used and the 50% inhibitory concentrations were determined by linear regression of log-transformed survival data. At 2.5 mM, the methylxanthine caffeine enhanced cisplatin sensitivity 2.9-fold in CAOV−3 cells and 2.7-fold in Me−180 cells. At 2.5 mM, pentoxifylline, a closely related methylxanthine, increased cisplatin sensitivity 2.9-fold in CAOV−3 cells and 3.4-fold in Me−180 cells. Chemical modification of cisplatin-induced cytotoxicity by assumed inhibition of DNA-repair mechanisms may hold promise for clinical application in the treatment of gynecological cancer.
Similar content being viewed by others
Abbreviations
- PTX:
-
pentoxifylline
References
Alberts D, Chen G (1980) Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In: Salmon S (ed) Cloning of human tumor stem cells. Liss, New York, pp 351–359
Beermann B, Ings R, Mansby J, Chamberlain J, McDonald A (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37:25–28
Biddle W, Ambrus C, Gastpar H, Ambrus J (1984) Antineoplastic effect of the xanthine derivative trental. J Med 15:355–366
Chou T, Talaly P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55
Collins A (1987) Cellular responses to ionizing radiation: effects of interrupting DNA repair with chemical agents. Int J Radiat Biol 51:971–983
Dixon W (ed) (1988) BMDP statistical software manual. University of California, Berkeley, Calif.
Dobmeyer D, Stine R, Leier C, Greenberg R, Schaal S (1983) The arrhymogenic effects of caffeine in human beings. N Engl J Med 308:814–816
Fingert H, Chang J, Pardee A (1986) Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res 46:2463–2467
Fingert H, Pu A, Chen Z, Googe P, Alley M, Pardee A (1988) In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa. Cancer Res 48:4375–4381
Fojo A, Hamilton T, Young R, Ozols R (1987) Multidrug resistance in ovarian cancer. Cancer 60:2075–2080
Hamilton T, Young R, Ozols R (1984) Experimental model systems of ovarian cancer; applications to the design and evaluation of new treatment approaches. Semin Oncol 11:285–298
Kelland L, Steel G (1988) Modification of radiation dose-rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair. Int J Radiat Biol 54:229–244
Masuda H, Ozols R, Lai G, Fojo A, Rothenberg M, Hamilton T (1988) Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum in human ovarian cancer cell lines. Cancer Res 48:5713–5716
Moscow J, Cowan K (1988) Multidrug resistance. J Natl Cancer Inst 80:14–20
Mouelatos D, Dozi-Vassiliades J, Kotsis A, Gourtsas C (1988) Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo. Cancer Res 48:1129–1131
SAS User's Guide (1985) Statistics. 5th edn, Carey, N. C.
Scanlon K, Kashani-Sabet M, Sowers L (1989) Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HTC8 cells and circumvention by azidothymidine. Cancer Commun 1:269–275
Schneider J, Martin M, Erasun F, Matia J, Rodriguez-Escudero F (1990) Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Oncology 47:109–111
Sevin BU, Peng Z, Perras J, Ganjei P, Penalver M, Averette H (1988) Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing. Gynecol Oncol 31:191–204
Tomita K, Tsuchiya H, Sasaki T (1989) DNA repair and drug resistance: Enhancement of the effects of anticancer agents by DNA repair inhibitors. Gan To Kagaku Ryoho 16:576–584
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med. D. Schmähl on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Petru, E., Boike, G. & Sevin, B.U. Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J Cancer Res Clin Oncol 116, 431–433 (1990). https://doi.org/10.1007/BF01612988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612988